U.S. Interactive Media and Services Stock News

Earlier in June 2026, Cullinan Therapeutics reported updated Phase 1 data showing its bispecific T cell engagers CLN-978 and velinotamig produced strong clinical responses and favorable safety in heavily pre-treated rheumatoid arthritis and systemic lupus erythematosus patients, including remissions and complete renal responses in lupus nephritis. By positioning T cell engagers as off-the-shelf “immune reset” therapies across multiple autoimmune conditions, Cullinan is expanding its...

In recent months, Extreme Networks has accelerated its transition toward subscription-based cloud management software, shifting more of its business toward recurring, software-led revenue streams. This move is aligning the company more closely with long-term trends in hybrid work, device connectivity, AI workloads, and cloud adoption, which are drawing increasing attention from institutional investors and technical analysts. Next, we’ll examine how Extreme Networks’ subscription-based cloud...

The Morning Bull - US Market Morning Update Wednesday, Jun, 24 2026 US stock futures are pointing lower this morning, with E mini S&P 500 contracts down about 1.5% and Nasdaq 100 futures off roughly 2.8%, as investors weigh weaker global growth signals against a firm interest rate backdrop. Across Europe, key business surveys such as the Euro Area composite PMI sit below 50 at 49.5, which means private sector activity is still shrinking, while UK services have slipped further into contraction...

The overhaul of the US student loan system is set to squeeze the budgets of millions of younger consumers, which could matter a lot for stocks tied to everyday essentials. With higher required repayments and less generous forgiveness, some households may rethink where every extra dollar goes, while spending on staples may hold up differently than more discretionary categories. This article looks at three consumer staples stocks from our screener that are closely exposed to this student debt...

With services activity soft in Europe, inflation pressures lingering across regions and policy expectations shifting around interest rates, many investors are looking for income that feels more resilient than short term market swings. The Dividend Fortresses screener focuses on stocks offering 5%+ dividend yields with an emphasis on stability, which can help you keep cash flows front and center while sentiment and growth data move around. In this article, you will see three of the strongest...

Sharplink (SBET) is drawing attention after another weak trading session, with the stock down 6.5% on the day and extending declines seen over the past week, month and past 3 months. See our latest analysis for Sharplink. At a latest share price of $4.97, Sharplink’s weak 1-day, 7-day and 30-day share price returns, along with a 1-year total shareholder return down 48.6% and 3-year total shareholder return down 85.17%, point to fading momentum as investors reassess growth prospects and risk...

In June 2026, iQIYI released the psychological thriller “None Shall Escape” on its domestic and international platforms, showcasing one of the first feature films produced using its NadouPro AI production system, which materially lifted visual effects shot efficiency and compressed complex post-production timelines. Since opening for commercial use in April, NadouPro has attracted more than 10,000 active creators and supported over 100 iQIYI original projects, signaling early traction for...

Thermo Fisher Scientific (TMO) is back in the spotlight after using the BIO International 2026 convention in San Diego to showcase AI driven research tools and integrated drug development workflows for pharma and biotech clients. See our latest analysis for Thermo Fisher Scientific. Thermo Fisher Scientific’s recent AI focus at BIO International comes after a mixed stretch for the stock, with the share price down 20.79% year to date but a 1 year total shareholder return of 16.49% signaling...

Western Midstream Partners, LP recently filed an omnibus shelf registration covering common and preferred units and Western Midstream Operating, LP debt securities, and its subsidiary priced a US$700,000,000 offering of 5.7% senior notes due 2036 to repay borrowings and fund capital expenditures. A second produced-water treatment pilot facility in Reeves County, Texas, built with Chevron, ConocoPhillips, Devon, and ExxonMobil, significantly expands Western Midstream’s reclaimed freshwater...

Byline Bancorp’s first-quarter 2026 results, reported earlier this year, showed earnings per share of US$0.83, ahead of analyst expectations of US$0.75 despite a slight revenue shortfall. This earnings outperformance, coming alongside only a modest revenue miss, points to improved efficiency and cost control as key drivers of profitability. With earnings beating expectations, we’ll explore how this profit strength influences Byline Bancorp’s existing investment narrative and risk-return...

Keel Infrastructure (KEEL) is back in focus after investors reacted to new government backed project wins and a multi year contracts pipeline that has pushed trading volumes higher and highlighted its AI infrastructure ambitions. See our latest analysis for Keel Infrastructure. Keel Infrastructure’s share price has been on a strong run, with a 30 day share price return of 30.77% and a 90 day share price return of 184.62%. Its 1 year total shareholder return is about 7x, reflecting rising...

Earlier in June 2026, Crinetics Pharmaceuticals presented new clinical data at ENDO 2026, including Phase 2 results for investigational atumelnant in congenital adrenal hyperplasia and long-term open-label extension findings for once-daily oral PALSONIFY in acromegaly. The combination of biomarker reductions and glucocorticoid dose lowering with atumelnant, alongside multi-year PALSONIFY efficacy and safety data, underscores Crinetics’ potential breadth in endocrine care. We’ll now examine...

Universal Health Services recently reported quarterly revenue of US$4.50 billion, an increase of 9.6% year on year, and exceeded analyst expectations on both revenue and earnings. In parallel, the company was recognized by Newsweek and Plant A Insights Group as one of America’s Greatest Workplaces in Health Care 2026, underscoring how its workplace culture may support ongoing operational execution. With this strong earnings beat and workplace recognition in mind, we’ll now explore how these...

Quantum computing has moved from theory to policy priority, and the latest US executive orders on quantum adoption and quantum-resistant encryption put that shift in sharp focus. With plans for a national lab-based quantum computer by 2028, plus federal grants and funding streams tied to the CHIPS and Science Act, stocks exposed to this news, such as D-Wave Quantum, are firmly on investors’ radar. This article walks through 3 stocks from our Quantum Computing Stocks With US Government Growth...

Recent Performance Snapshot for USA Compression Partners USA Compression Partners (USAC) has drawn fresh attention after a recent move in its unit price, with the stock up 2.7% over the past day and 2.0% over the past week. Despite that short term uptick, units are down about 9.7% over the past month and 7.0% over the past 3 months, which may prompt investors to reassess how current pricing lines up with the partnership’s fundamentals. See our latest analysis for USA Compression Partners. Set...

AI related spending by the Magnificent Seven is projected to reach US$668b in 2026, while higher for longer interest rates keep pressure on tech valuations and funding costs. That mix of heavy capital expenditure and tighter money puts a spotlight on one thing: free cash flow. Investors are asking which stocks can keep generating cash even as they invest in AI infrastructure, and which might struggle if returns are slower than hoped. This article looks at 3 stocks from a High Free Cash Flow...

On Holding (ONON) is in focus after its shift from a pure running label to a premium lifestyle brand, supported by new cushioning technologies and recent quarterly results that showed higher revenue and wider margins. See our latest analysis for On Holding. Despite the strong Q1 revenue and margin figures, On Holding’s share price has been under pressure, with the 30 day share price return down 11.73% and the year to date share price return down 25.15%. Over a longer horizon, the 3 year total...

Veeva Systems recently reported fiscal Q1 2027 results with double-digit revenue and subscription growth, beating its own guidance and lifting its full-year outlook. At the same time, Veeva accelerated its push into AI with new agent-based platform plans and the acquisitions of Ostro and Copli, deepening automation across life sciences workflows. We’ll now explore how Veeva’s stronger outlook and push into AI-powered agentic solutions could reshape the company’s broader investment...

In June 2026, ZenaTech, Inc. unveiled Zoo Office, an AI-powered unified productivity platform intended to become the core foundation and brand for its Enterprise SaaS ecosystem, initially rolling out via a private beta targeting small and medium-sized businesses. The Zoo Office roadmap is distinctive because it aims to combine agentic AI, core productivity tools, and industry-specific applications into a single connected platform that reduces subscription sprawl and fragmented workflows. We...

In recent days, Philip Morris International announced new regional leadership appointments effective August 1, 2026, while also affirming a quarterly dividend of US$1.4700 per share payable on July 20, 2026. Together with recent regulatory signals in the EU and the U.S. that appear to reduce perceived policy risk, these moves highlight how governance, cash returns, and the regulatory backdrop are all shaping Philip Morris International’s smoke-free transition. We’ll now examine how the...

UDR (UDR) is back on investors’ radar after recent trading put the stock near its latest close of US$38.28. This has prompted fresh interest in how this multifamily REIT’s returns compare with its fundamentals. See our latest analysis for UDR. Recent moves in UDR’s share price, including a 1.43% one-day share price return and a 12.82% 90-day share price return, contrast with a 1-year total shareholder return that declined 2.12%. This suggests improving short-term momentum following a weaker...

DoorDash (DASH) is in focus after announcing a partnership with Dollar Tree that brings on demand delivery to more than 9,000 stores across 48 states and expands its presence in value focused retail. See our latest analysis for DoorDash. The Dollar Tree partnership lands as DoorDash stock shows mixed momentum, with a 30 day share price return of 7.03% and a 90 day gain of 12.16%. However, the stock has a year to date decline of 21.96% and a 1 year total shareholder return down 27.37%, while...

Penny stocks usually live or die on one thing, cash. In a world where growth signals are mixed across Europe, the UK, North America and Asia, and where energy prices, inflation and policy decisions can shift sentiment quickly, having a solid balance sheet matters even more for smaller companies. The Elite Penny Stocks screener focuses on stocks that still trade at penny levels but have the financial strength to keep funding their plans. In this article, you will see 3 of the best stocks from...

United States Antimony (UAMY) is back on investors’ radar after recent trading highlighted sharp share price moves, alongside mixed return figures that include gains year to date but declines over the past month and over the past 3 months. See our latest analysis for United States Antimony. Recent trading in United States Antimony has been choppy, with a 1-day share price return of down 10.13% to $7.01 and a 30-day share price return of down 16.75%. At the same time, the year to date share...